Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

by admin May 19, 2025
May 19, 2025
Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

Former President Joe Biden’s office confirmed on Sunday that he is undergoing treatment for prostate cancer. 

‘Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms,’ Biden’s team shared in a statement. ‘On Friday, he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone.’ 

‘While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians,’ the statement continued.

This is a developing story. Please check back for updates. 

Stepheny Price is a writer for Fox News Digital and Fox Business. She covers topics including missing persons, homicides, national crime cases, illegal immigration, and more. Story tips and ideas can be sent to stepheny.price@fox.com

This post appeared first on FOX NEWS

previous post
Rubio teases details of potential Trump, Putin in-person meeting after Russia-Ukraine ceasefire talks stall
next post
Biden’s woes converge: Last-minute pardons under fire, calls for prosecution mount following Hur tape release

Related Posts

Failed VP candidate Tim Walz skewered after hinting...

March 4, 2025

FBI botched investigation into Hillary Clinton’s emails, declassified...

July 22, 2025

House Republicans demand Trump admin deny Mamdani federal...

November 22, 2025

Judges blocking Trump’s executive orders are acting ‘erroneously,’...

March 20, 2025

Gabbard removes clearances from 37 officials at Trump’s...

August 20, 2025

Vance triggers Dems by defending Trump’s executive authority

February 11, 2025

Israel’s actions against Iran create strategic opportunity for...

June 15, 2025

Israel to deploy first combat-ready laser weapon system...

October 16, 2025

His brother’s keeper: Gal Dalal pleads for help...

March 22, 2025

American Airlines flight carrying US lawmakers ‘bumped’ by...

April 11, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 2

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Rare Earths Stocks: 9 Biggest Companies in 2025

      April 8, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 7

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 daytradingreports.com | All Rights Reserved